Elsevier

Neuropharmacology

Volume 25, Issue 2, February 1986, Pages 187-197
Neuropharmacology

Dopamine D2 receptors and dopamine metabolism: Relationship between biochemical and behavioural effects of substituted benzamide drugs

https://doi.org/10.1016/0028-3908(86)90040-7Get rights and content

Abstract

The effect of the substituted benzamide dopamine D2 receptor antagonists sulpiride, raclopride, FLA 966(−), FLA 988(−), eticlopride and remoxipride as well as the “classical” dopamine antagonists, haloperidol and chlorpromazine, on the concentrations of dopamine, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat was investigated. All compounds increased the turnover of dopamine, as defined by increased concentrations of DOPAC and HVA (without change in the concentration of dopamine) in the striatum in a dose-dependent manner. The doses of the compounds producing increased turnover of dopamine in the striatum were in the same range as those displacing the in vivo binding of [3H]spiperone in the striatum. In addition for all the compounds tested in the study, an increase in the turnover of dopamine to about 300% of control was observed for doses antagonising the stereotypy produced by the dopamine agonist, apomorphine. On the other hand, no consistent relationship between increased turnover of dopamine and the doses of the compounds required to antagonise apomorphine-induced hyperactivity was found. This result was also found in limbic areas. Remoxipride and haloperidol had little or no effect on the turnover of dopamine in either the hypothalamus or substantia nigra at the ED50 doses of these compounds for antagonism of apomorphine-induced stereotypy.

References (38)

  • S.O. Ögren et al.

    Behavioural effects of ergot drugs

  • S-O. Ögren et al.

    Remoxipride a new potential anti-psychotic compound with selective anti-dopaminergic actions in the rat brain

    Eur. J. Pharmac.

    (1984)
  • S. Bischoff et al.

    The dopaminergic system in the hippocampus: site of action for antipsychotic activity of neuroleptics?

    J. Neurochem.

    (1983)
  • B.S. Bunney et al.

    Dopaminergic neurones: effect of antipsychotic drugs and amphetamine on single cell activity

    J. Pharmac. exp. Ther.

    (1973)
  • A. Carlsson et al.

    Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain

    Acta pharmac. tox.

    (1963)
  • J.K. Chivers et al.

    Comparison of the in vivo displacement of 3H-spiperone by haloperidol and sulpiride with inhibition of apomorphine induced stereotypy and increased dopamine turnover

    Neurosci. Lett.

    (1983)
  • E.R. Cools et al.

    The nucleus accumbens of rats and dopaminergic mechanisms regulating locomotor behaviour

    Neurosci. Lett.

    (1976)
  • W.W. Daniel

    Theil's method

  • H.C. Fibiger et al.

    On the problem of distinct lesions in behavioural studies utilizing kainic acid

  • Cited by (60)

    • Pharmacology profile of F17464, a dopamine D<inf>3</inf> receptor preferential antagonist

      2021, European Journal of Pharmacology
      Citation Excerpt :

      F17464 pre-treatment time in this case was chosen in consideration of the high 5-HT1a receptor affinity of both F17464 and the tracer radioligand [3H]WAY100635 (Parkel and Rinken, 2006). Antipsychotics can modify dopamine turnover in the rodent central nervous system (Cartmell et al., 2000; Magnusson et al., 1986) and atypical antipsychotics can increase dopamine release in medial prefrontal cortex (Ichikawa et al., 2001; Tanda et al., 2015). F17464 (0.04, 0.16, 0.63, and 2.5 mg/kg) or saline was administered i.p. To NMRI mice (8/group) 60 min before sacrifice by microwaves (4.2 kW, 0.9–1.1 s, Sacron8000™, SAIREM, Vaulx-en-Yelin, FR) (Wasek et al., 2018).

    • The Influence of Metoclopramide on Trigeminovascular Nociception: Possible Anti-migraine Mechanism of Action

      2020, Neuroscience
      Citation Excerpt :

      Moreover, haloperidol and a selective D2-like receptor antagonist eticlopride were able to amplify the phasic dopamine signalling via a direct inhibitory action on dopamine uptake (Benoit-Marand et al., 2011). Metoclopramide (5–100 mg/kg, intraperitoneally) (Miller, 1976) and other D2 receptor antagonists (including haloperidol and chlorpromazine) (Magnusson et al., 1986) significantly enhanced dopamine striatal turnover in rodents. Likewise, blockade of presynaptic D2 autoreceptors on dopaminergic projections from the A11 nucleus, which provide the main source of dopamine in the TCC (Charbit et al., 2009a), would enhance extracellular dopamine level and, therefore, the tonic inhibitory dopamine action mediated by postsynaptic D2 receptors on the second-order trigeminal neurons (Charbit et al., 2009a,b; Lapirot et al., 2011).

    • Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats

      2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Evidence also supports the hypothesis that pyschostimulant-induced stereotypy is mediated through postsynaptic dopamine receptors (Feldman et al., 1997). Furthermore, it has been shown that dopamine D2 receptor antagonists inhibit stereotyped behaviors in rats (Magnusson et al., 1986). Thus, attenuation of ethanol withdrawal-induced stereotyped behaviors by risperidone and quetiapine, which are both dopamine D2 receptor antagonists, is not surprising.

    • The relationship between baseline prepulse inhibition levels and ethanol withdrawal severity in rats

      2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      These observations may be related to the involvement of the similar receptor systems in mediating baseline PPI and EWS-induced stereotyped behaviors and wet-dog shakes. Stimulation of dopamine D1 and D2 receptors induces stereotyped behaviors (Dall'Olio et al., 1988), while D2 receptor antagonists can inhibit stereotyped behaviors in rats (Magnusson et al., 1986). Stimulation of the serotonergic system has been implicated in increased wet-dog shakes because blockade of serotonin 5-HT2 receptors inhibited wet-dog shakes in rats (Takao et al., 1995).

    View all citing articles on Scopus
    View full text